| Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic A Dunlop, B Lokuge, D Masters, M Sequeira, P Saul, G Dunlop, J Ryan, ... Harm reduction journal 17 (1), 26, 2020 | 295 | 2020 |
| Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a … R Lazarus, S Baos, H Cappel-Porter, A Carson-Stevens, M Clout, ... The Lancet 398 (10318), 2277-2287, 2021 | 130 | 2021 |
| Fibrosis assessment in patients with chronic hepatitis B virus (HBV) infection P Parikh, JD Ryan, EA Tsochatzis Annals of translational medicine 5 (3), 2017 | 118 | 2017 |
| Expenditure freeze: the metabolic response of small mammals to cold environments MM Humphries, S Boutin, DW Thomas, JD Ryan, C Selman, AG McAdam, ... Ecology letters 8 (12), 1326-1333, 2005 | 116 | 2005 |
| Non-invasive markers of liver fibrosis: adjuncts or alternatives to liver biopsy? JL Chin, M Pavlides, A Moolla, JD Ryan Frontiers in pharmacology 7, 197597, 2016 | 113 | 2016 |
| A voxel-based morphometry study reveals local brain structural alterations associated with ambient fine particles in older women R Casanova, X Wang, J Reyes, Y Akita, ML Serre, W Vizuete, HC Chui, ... Frontiers in human neuroscience 10, 495, 2016 | 106 | 2016 |
| Hepatic iron is the major determinant of serum ferritin in NAFLD patients JD Ryan, AE Armitage, JF Cobbold, R Banerjee, O Borsani, ... Liver International 38 (1), 164-173, 2018 | 97 | 2018 |
| Defective bone morphogenic protein signaling underlies hepcidin deficiency in HFE hereditary hemochromatosis JD Ryan, E Ryan, A Fabre, MW Lawless, J Crowe Hepatology 52 (4), 1266-1273, 2010 | 86 | 2010 |
| PYY plays a key role in the resolution of diabetes following bariatric surgery in humans C Guida, SD Stephen, M Watson, N Dempster, P Larraufie, T Marjot, ... EBioMedicine 40, 67-76, 2019 | 79 | 2019 |
| Multiplexed LC-MS/MS method for the simultaneous quantitation of three novel hepatitis C antivirals, daclatasvir, asunaprevir, and beclabuvir in human plasma H Jiang, H Kandoussi, J Zeng, J Wang, R Demers, T Eley, B He, R Burrell, ... Journal of pharmaceutical and biomedical analysis 107, 409-418, 2015 | 73 | 2015 |
| EASL clinical practice guidelines on haemochromatosis H Zoller, B Schaefer, A Vanclooster, B Griffiths, E Bardou-Jacquet, ... Journal of Hepatology 77 (2), 479-502, 2022 | 67 | 2022 |
| Pegylated interferon‐α induced hypoferremia is associated with the immediate response to treatment in hepatitis C JD Ryan, S Altamura, E Devitt, S Mullins, MW Lawless, MU Muckenthaler, ... Hepatology 56 (2), 492-500, 2012 | 65 | 2012 |
| AKR1D1 is a novel regulator of metabolic phenotype in human hepatocytes and is dysregulated in non-alcoholic fatty liver disease N Nikolaou, LL Gathercole, L Marchand, S Althari, NJ Dempster, ... Metabolism 99, 67-80, 2019 | 60 | 2019 |
| A multidisciplinary approach to the management of NAFLD is associated with improvement in markers of liver and cardio-metabolic health A Moolla, K Motohashi, T Marjot, A Shard, M Ainsworth, A Gray, R Holman, ... Frontline gastroenterology 10 (4), 337-346, 2019 | 60 | 2019 |
| Therapeutic recommendations in HFE hemochromatosis for p.Cys282Tyr (C282Y/C282Y) homozygous genotype P Adams, A Altes, P Brissot, B Butzeck, I Cabantchik, R Cançado, ... Hepatology international 12, 83-86, 2018 | 55 | 2018 |
| Tenofovir alafenamide for the treatment of chronic hepatitis B virus infection S Abdul Basit, A Dawood, J Ryan, R Gish Expert review of clinical pharmacology 10 (7), 707-716, 2017 | 47 | 2017 |
| The excavation of a large earthen ring-fort at Garranes, Co. Cork SP Ó Ríordáin, J Ryan Proceedings of the Royal Irish Academy. Section C: Archaeology, Celtic …, 1941 | 46 | 1941 |
| Blood alanine aminotransferase levels> 1,000 IU/l–causes and outcomes Z Galvin, A McDonough, J Ryan, S Stewart Clinical medicine 15 (3), 244, 2015 | 43 | 2015 |
| Spleen stiffness can non‐invasively assess resolution of portal hypertension after liver transplantation JL Chin, G Chan, JD Ryan, PA McCormick Liver International 35 (2), 518-523, 2015 | 42 | 2015 |
| An international multidisciplinary consensus statement on MAFLD and the risk of CVD XD Zhou, G Targher, CD Byrne, V Somers, SU Kim, CAA Chahal, ... Hepatology international 17 (4), 773-791, 2023 | 34 | 2023 |
